UTHR vs VTRS · P/E 20, rev $1.56B vs rev $7.27B
United Therapeutics Corporation (UTHR) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
UTHR currently screens at market cap $23.41B and trailing P/E 20.4. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the UTHR and VTRS stock pages for the full models.
Not investment advice.